Echocardiographic Parameters to Predict Atrial Fibrillation in Clinical Routine-The EAHsy-AF Risk Score.
PA-TDI interval
atrial fibrillation
atrial remodeling atrial fibrillation
echocardiography
prediction
score
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
09
01
2022
accepted:
14
02
2022
entrez:
30
3
2022
pubmed:
31
3
2022
medline:
31
3
2022
Statut:
epublish
Résumé
Echocardiographic parameters representing impaired left atrial (LA) function and remodeling are of high value to predict atrial fibrillation (AF). This study aimed to develop a prediction model for AF easily to apply in clinical routine containing echocardiographic parameters associated with LA remodeling and-function. This monocentric, semi-blinded, controlled analysis included 235 patients to derive a prediction model. This prediction model was tested in a validation cohort encompassing 290 cardiovascular inpatients. The derivation and validation cohort included 54 (23%) and 66 (23%) patients with AF, respectively. Transthoracic echocardiography, comprising parameters indicating left atrial remodeling [septal/lateral total atrial conduction time (s/l PA-TDI)] and left atrial volume indexed to a' (LAVI/a') was performed in each patient. Based on multivariable regressions analysis, four variables were enclosed into the EAHsy (Echocardiography, Age, Hypertension)-AF risk score for AF prediction: Hypertension, Age, LAVI/a' and septal PA-TDI. In the validation cohort discrimination was strong (C-statistic 0.987, 95%CI 0.974-0.991) with an adequately performed calibration. The EAHsy-AF risk score was associated with a more precise prediction of AF in comparison to commonly used AF-scores (CHADS The EAHsy-AF-Score containing age, hypertension and echocardiographic parameters of atrial dysfunction and remodeling precisely predicts the incidence of AF in a general population of patients with cardiovascular disease. The EAHsy-AF risk score may enable more selective rhythm monitoring in specific patients at high risk for AF.
Sections du résumé
Background
UNASSIGNED
Echocardiographic parameters representing impaired left atrial (LA) function and remodeling are of high value to predict atrial fibrillation (AF). This study aimed to develop a prediction model for AF easily to apply in clinical routine containing echocardiographic parameters associated with LA remodeling and-function.
Methods and Results
UNASSIGNED
This monocentric, semi-blinded, controlled analysis included 235 patients to derive a prediction model. This prediction model was tested in a validation cohort encompassing 290 cardiovascular inpatients. The derivation and validation cohort included 54 (23%) and 66 (23%) patients with AF, respectively. Transthoracic echocardiography, comprising parameters indicating left atrial remodeling [septal/lateral total atrial conduction time (s/l PA-TDI)] and left atrial volume indexed to a' (LAVI/a') was performed in each patient. Based on multivariable regressions analysis, four variables were enclosed into the EAHsy (Echocardiography, Age, Hypertension)-AF risk score for AF prediction: Hypertension, Age, LAVI/a' and septal PA-TDI. In the validation cohort discrimination was strong (C-statistic 0.987, 95%CI 0.974-0.991) with an adequately performed calibration. The EAHsy-AF risk score was associated with a more precise prediction of AF in comparison to commonly used AF-scores (CHADS
Conclusion
UNASSIGNED
The EAHsy-AF-Score containing age, hypertension and echocardiographic parameters of atrial dysfunction and remodeling precisely predicts the incidence of AF in a general population of patients with cardiovascular disease. The EAHsy-AF risk score may enable more selective rhythm monitoring in specific patients at high risk for AF.
Identifiants
pubmed: 35350539
doi: 10.3389/fcvm.2022.851474
pmc: PMC8957789
doi:
Types de publication
Journal Article
Langues
eng
Pagination
851474Informations de copyright
Copyright © 2022 Sieweke, Hagemus, Biber, Berliner, Grosse, Schallhorn, Pfeffer, Derda, Neuser, Bauersachs and Bavendiek.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Clin Med. 2020 Apr 14;9(4):
pubmed: 32295105
Clin Res Cardiol. 2017 Oct;106(10):767-775
pubmed: 28382425
Europace. 2018 Nov 1;20(FI_3):f428-f435
pubmed: 29016770
Eur Heart J Cardiovasc Imaging. 2016 Apr;17(4):355-83
pubmed: 26864186
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Circ Res. 2017 Feb 3;120(3):439-448
pubmed: 28154096
Hypertension. 2010 May;55(5):1150-6
pubmed: 20368506
Am J Cardiol. 2011 Jan;107(1):85-91
pubmed: 21146692
Chest. 2010 Feb;137(2):263-72
pubmed: 19762550
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3334-3338
pubmed: 33090608
N Engl J Med. 2014 Jun 26;370(26):2467-77
pubmed: 24963566
Stroke. 2011 Dec;42(12):3643-5
pubmed: 21998056
JAMA. 2001 Jun 13;285(22):2864-70
pubmed: 11401607
Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007213
pubmed: 31610692
Clin Res Cardiol. 2018 Oct;107(10):871-880
pubmed: 29704214
Arch Intern Med. 2004 Aug 9-23;164(15):1675-8
pubmed: 15302638
J Am Heart Assoc. 2019 Jul 2;8(13):e012546
pubmed: 31234697
Heart Lung Circ. 2019 Nov;28(11):1664-1669
pubmed: 30527848
Int J Cardiol. 2014 May 15;173(3):441-6
pubmed: 24713455
Clin Res Cardiol. 2020 Feb;109(2):205-214
pubmed: 31236691
Europace. 2020 May 1;22(5):684-694
pubmed: 32011689
Stroke. 2012 Oct;43(10):2788-90
pubmed: 22871679
Am Heart J. 2016 Aug;178:45-54
pubmed: 27502851
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465
N Engl J Med. 2014 Jun 26;370(26):2478-86
pubmed: 24963567
Europace. 2009 Jan;11(1):11-7
pubmed: 18988654
Neurology. 2010 May 25;74(21):1662-3
pubmed: 20498433
Circ Cardiovasc Imaging. 2010 May;3(3):231-9
pubmed: 20133512
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Circulation. 2003 Sep 2;108(9):1146-62
pubmed: 12952829
J Cardiovasc Electrophysiol. 2013 Jun;24(6):626-31
pubmed: 23398627
J Am Heart Assoc. 2013 Mar 18;2(2):e000102
pubmed: 23537808
Heart Rhythm. 2011 Aug;8(8):1160-6
pubmed: 21419237
Lancet Neurol. 2017 Apr;16(4):282-290
pubmed: 28187920
Thromb Haemost. 2017 Oct 5;117(10):1962-1969
pubmed: 28862284
Cerebrovasc Dis. 2021;50(1):46-53
pubmed: 33311022
J Interv Card Electrophysiol. 2013 Jun;37(1):47-54
pubmed: 23389054
Stat Med. 2004 May 30;23(10):1631-60
pubmed: 15122742